Physician profile
Jorge E Salazar
NPI 1225012867
$6,635.86
in general payments reported to CMS, 2019-2025
11 companies · $2,400 in 2025
The $2,400 reported for 2025 was more than what 95% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $385 · 2020: $367 · 2021: $471 · 2022: $232 · 2023: $381 · 2024: $2,400 · 2025: $2,400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $5,033 · Food and Beverage: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $5,033.34 |
| Food and Beverage | $147.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $5,033.34 | 2023-2025 | Venacure 1470 Pro |
| Amgen INC. | $474.31 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $251.25 | 2020-2023 | Farxiga |
| Cagent Vascular INC | $231.57 | 2022 | |
| Janssen Pharmaceuticals, INC | $137.91 | 2019 | |
| Mannkind Corporation | $125.00 | 2019 | |
| Pfizer INC. | $122.53 | 2020 | |
| Novo Nordisk INC | $115.56 | 2021 | |
| Abbvie INC. | $108.87 | 2019 | |
| Hologic Sales and Service, LLC | $22.43 | 2023 | Aptima, Thinprep 2000 Processor |
| Sanofi Pasteur INC. | $13.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Salazar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.